CCMH
RIGL icon

Cornerstone Capital Management Holdings’s Rigel Pharmaceuticals RIGL Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,930
Closed -$144K – 1407
2016
Q3 		$144K Sell
3,930
-3,440
-47% -$98.6K ﹤0.01% 1228
2016
Q2 		$164K Buy
7,370
+920
+14% +$22.9K ﹤0.01% 1223
2016
Q1 		$134K Buy
6,450
+3,620
+128% +$89.3K ﹤0.01% 1277
2015
Q4 		$86K Buy
2,830
+760
+37% +$23K ﹤0.01% 1326
2015
Q3 		$51K Buy
+2,070
New +$61.8K ﹤0.01% 1402

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Cornerstone Capital Management Holdings's RIGL Position: Q4 2016 in Review

Cornerstone Capital Management Holdings sold out of Rigel Pharmaceuticals (RIGL) in Q4 2016, closing a stake of 3,930 shares — an estimated $144K sold.

Cornerstone Capital Management Holdings first reported a position in RIGL in Q3 2015 and held it in 5 quarters. The position peaked at $164K in Q2 2016. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • Cornerstone Capital Management Holdings reported no remaining Rigel Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 3,930 Rigel Pharmaceuticals shares in Q4 2016, an estimated $144K.
  • Cornerstone Capital Management Holdings first reported a position in Rigel Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Cornerstone Capital Management Holdings's Rigel Pharmaceuticals position peaked at $164K in Q2 2016.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.